04/09/2025
Have you recently been prescribed XERMELO for carcinoid syndrome diarrhea (CSD)?
TerSera NurseSupport is here to help you as you start your treatment journey. Through TerSera NurseSupport, you can connect with a clinical nurse educator (CNE) who can help with questions about starting XERMELO, advocacy connections, and nutrition and CSD education. Remember, your CNE is here to support and provide you with helpful resources, so you have the tools you need to feel confident about managing your condition. Enroll in TerSera NurseSupport today: bit.ly/XermeloAsk-a-Nurse
Indication
XERMELO is a prescription pill, used along with somatostatin analog (SSA) therapy, for carcinoid syndrome diarrhea in adults who are not adequately controlled by SSA therapy.
Important Safety Information
• Do not take XERMELO if you have a history of hypersensitivity to telotristat or any of the ingredients in XERMELO.
• XERMELO may cause constipation which can be serious. You should stop taking XERMELO if severe constipation or severe, persistent, or worsening abdominal pain develops. Talk to your doctor if you have these symptoms.
• The most common side effects of XERMELO include nausea, headache, increase in liver enzymes, depression, flatulence, decreased appetite, swelling of your hands and feet, fever, abdominal pain, and constipation.
• Talk to your doctor about all medications you are taking as some may interact with XERMELO.
• XERMELO is not recommended if you have moderate or severe liver impairment.
You are encouraged to report negative side effects of prescription drugs to the FDA. To report suspected adverse reactions, contact the FDA at 1-800-FDA-1088 or www.FDA.gov/medwatch. You may also contact TerSera Therapeutics at 1-844-334-4035 or medicalinformation@tersera.com.
Please see Full Prescribing Information: bit.ly/XERMELO_PI